The effects of progesterone pretreatment on the response to oral d-amphetamine in Women

Hormones and Behavior

Volumn 58, Issue 3, 2010, Pages 533-543

  Reed, Stephanie C ^a   Levin, Frances R ^a   Evans, Suzette M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Amphetamine; Cardiovascular Effects; Hormones; Impulsivity; Menstrual Cycle; Performance Effects; Progesterone; Stimulants; Subjective effects; Women

Indexed keywords

DEXAMPHETAMINE; ESTRADIOL; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; COGNITION; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; TASK PERFORMANCE;

ADMINISTRATION, ORAL; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MENSTRUAL CYCLE; PLACEBOS; PROGESTERONE; RISK-TAKING;

EID: 77955274938     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.04.003     Document Type: Article

References (91)

1. Anker J.J., Carroll M.E. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend. 2010, 107:264-267.
2. Anker J.J., Holtz N.A., Zlebnik N., Carroll M.E. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology 2009, 203:63-72.
3. Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp. Clin. Psychopharmacol. 2007, 15:472-480.
4. Asghar S.J., Tanay V.A., Baker G.B., Greenshaw A., Silverstone P.H. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Hum. Psychopharmacol. 2003, 18(4):291-299.
5. Beck A.T., Steer R.A., Ball R., Ranieri W.F. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J. Pers. Assess. 1996, 67:588-597.
6. Becker J.B., Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 1989, 35:117-125.
7. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 2002, 23:41-100.
8. Carroll, M.E., Anker, J.J., in press. Sex differences and ovarian hormones in animal models of drug dependence. Horm. Behav.
9. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 2004, 25:273-279.
10. Childs E., Van Dam N.T., de Wit H. Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp. Clin. Psychopharmacol. 2010, 18:78-86.
11. de Lignières B. Oral micronized progesterone. Clin. Ther. 1999, 21(1):41-60.
12. de Wit H., Crean J., Richards J.B. Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav. Neurosci. 2000, 114:830-837.
13. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27:813-825.
14. de Wit H., Schmitt L., Purdy R., Hauger R. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 2001, 26:697-710.
15. Dluzen D.E., Ramirez V.D. In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen. Neuroendocrinology 1990, 52:517-520.
16. Dougherty D.M., Marsh D.M. (IMT/DMT 2.0): a research tool for studying attention, memory, and impulsive behavior [Manual]. Neurobehavioral Research Laboratory and Clinic, University of Texas Health Science Center at Houston, Houston, TX 2003.
17. Dougherty D.M., Bjork J.M., Harper R.A., Mathias C.W., Moeller F.G., Marsh D.M. Validation of the immediate and delayed memory tasks in hospitalized adolescents with disruptive behavior disorders. Psychol. Rec. 2003, 53:509-532.
18. Dougherty D.M., Marsh-Richard D.M., Hatzis E.S., Nouvion S.O., Mathias C.W. A test of alcohol dose effects on multiple behavioral measures of impulsivity. Drug Alcohol Depend. 2008, 96:111-120.
19. Dougherty D.M., Marsh D.M., Mathias C.W. Immediate and delayed memory tasks: a computerized behavioral measure of memory, attention, and impulsivity. Behav. Res. Methods Instrum. Comput. 2002, 34:391-398.
20. Dougherty D.M., Mathias C.W., Marsh D.M. (version 1.0) [Manual]. Neurobehavioral Research Laboratory and Clinic, University of Texas Health Science Center at Houston, Houston, TX 2003.
21. Dougherty D.M., Mathias C.W., Marsh D.M., Jagar A.A. Laboratory behavioral measures of impulsivity. Behav. Res. Methods 2005, 37:82-90.
22. Evans S.M. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharmacol. 2007, 15:418-426.
23. Evans S.M., Foltin R.W. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?. Horm. Behav. 2010, 58:13-21.
24. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
25. Evans S.M., Foltin R.W., Fischman M.W. Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite 1999, 32:331-349.
26. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 2002, 159:397-406.
27. Evans S.M., Haney M., Levin F.R., Foltin R.W., Fischman M.W. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharm. 1998, 19:499-516.
28. Evans S.M., Troisi J.R., Griffiths R.R. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J. Pharmacol. Exp. Ther. 1994, 271:683-694.
29. Evenden J., Ko T. The psychopharmacology of impulsive behaviour in rats VIII: effects of amphetamine, methylphenidate, and other drugs on responding maintained by a fixed consecutive number avoidance schedule. Psychopharmacology 2005, 180:294-305.
30. Eysenck S.B.G., Pearson P.R., Easting G., Allsopp J.F. Age norms for impulsiveness, venturesomeness and empathy in adults. Person Individ. Differ. 1985, 6:613-619.
31. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine-seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34:343-352.
32. Feltenstein M.W., See R.E. Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle. Drug Alcohol Depend. 2007, 89(2-3):183-189.
33. Fillmore M.T., Kelly T.H., Martin C.A. Effects of d-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend. 2005, 77:151-159.
34. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders - Patient Edition (SCID-I/P, version 2.0) Biometrics Research Department 1995, New York State Psychiatric Institute, New York, NY.
35. Freeman E.W., Weinstock L., Rickels K., Sondheimer S.J., Coutifaris C. A placebo-controlled study of effects of oral progesterone on performance and mood. Br. J. Clin. Pharmacol. 1992, 33:293-298.
36. Frishman G.N., Klock S.C., Luciano A.A., Nulsen J.C. Efficacy of oral micronized progesterone in the treatment of luteal phase defects. J. Reprod. Med. 1995, 40:521-524.
37. Griffiths R.R., Rush C.R., Puhala K.A. Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Exp. Clin. Psychopharmacol. 1996, 4:97-106.
38. Griffiths R.R., Troisi J.R., Silverman K., Mumford G.K. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav. Pharmacol. 1993, 4:3-13.
39. Hamidovic A., Dlugos A., Palmer A.A., de Wit H. Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of d-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. Behav. Genet. 2010, 40:255-261.
40. Hart C.L., Gunderson E.W., Perez A., Kirkpatrick M.G., Thurmond A., Comer S.D., Foltin R.W. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 2008, 33:1847-1855.
41. Hart C.L., Haney M., Nasser J., Foltin R.W. Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol. Biochem. Behav. 2005, 81:559-568.
42. Holdcraft L.C., Iacono W.G. Cross-generational effects on gender differences in psychoactive drug abuse and dependence. Drug Alcohol Depend. 2004, 74:147-158.
43. Jackson L.R., Robinson T.E., Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 2006, 31(1):129-138.
44. Johnson B., Overton D., Wells L., Kenny P., Abramson D., Dhother S., Chen Y.R., Bordnick P. Effects of acute intravenous cocaine on cardiovascular function, human learning, and performance in cocaine addicts. Psychiatry Res. 1998, 77:35-42.
45. Justice A.J., de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 1999, 145:67-75.
46. Kaloyanides K.B., McCabe S.E., Cranford J.A., Teter C.J. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy 2007, 27:666-674.
47. Kelly T.H., Robbins G., Martin C.A., Fillmore M.T., Lane S.D., Harrington N.G., Rush C.R. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 2006, 189:17-25.
48. Kirby K.N., Marakovic N.N. Delay-discounting probabilistic rewards: rates decrease as amounts increase. Psychonom. Bull. Rev. 1996, 3:100-104.
49. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 1999, 128:78-87.
50. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp. Clin. Psychopharmacol. 2007, 15(5):461-471.
51. Lejuez C.W., Read J.P., Kahler C.W., Richards J.B., Ramsey S.E., Stuart G.L., Strong G.R., Brown R.A. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J. Exp. Psychol. Appl. 2002, 8:75-84.
52. Lile J.A., Kendall S.L., Babalonis S., Martin C.A., Kelly T.H. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacol. Biochem. Behav. 2007, 87:258-266.
53. Llaneza D.C., Frye C.A. Progestogens and estrogen influence impulsive burying and avoidant freezing behavior of naturally cycling and ovariectomized rats. Pharmacol. Biochem. Behav. 2009, 93:337-342.
54. Lord S., Downs G., Furtaw P., Chaudhuri A., Silverstein A., Gammaitoni A., Budman S. Nonmedical use of prescription opioids and stimulants among student pharmacists. J. Am. Pharm. Assoc. 2009, 49:519-528.
55. Makris A.P., Rush C.R., Frederich R.C., Taylor A.C., Kelly T.H. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp. Clin. Psychopharmacol. 2007, 15:123-133.
56. Martin C.S., Earleywine M., Musty R.E., Perrine M.W., Swift R.M. Development and validation of the Biphasic Alcohol Effects Scale. Alcohol. Clin. Exp. Res. 1993, 17:140-146.
57. Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber H.D. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D2/D3 receptors following acute dopamine depletion. Am. J. Psychiatry 2009, 166:1170-1177.
58. McCabe S.E., Teter C.J., Boyd C.J. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst. Use Misuse 2004, 39:1095-1116.
59. McLeod D., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods Instrum. 1982, 14:463-466.
60. McNair D., Lorr M., Droppleman L.F. Profile of mood states 1971, Educational and Industrial Testing Services, San Diego.
61. Mello N.K., Knudson I.M., Mendelson J.H. Sex and menstrual cycle effects on progressive ratio measures of cocaine self-administration in cynomolgus monkeys. Neuropsychopharmacology 2007, 32:1956-1966.
62. Michanek A., Meyerson B.J. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine. Pharmacol. Biochem. Behav. 1982, 16:875-879.
63. Niyomchai T., Akhavan A., Festa E.D., Lin S.N., Lamm L., Foltz R., Quiñones-Jenab V. Estrogen and progesterone affect cocaine pharmacokinetics in female rats. Brain Res. Bull. 2006, 68:310-314.
64. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt Impulsiveness Scale. J. Clin. Psychol. 1995, 51:768-774.
65. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 1992, 6:2311-2322.
66. Petitclerc M., Bédard P.J., Di Paolo T. Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995, 19:491-497.
67. Petry N.M. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl). 2001, 154(3):243-250.
68. Petry N.M., Kirby K.N., Kranzler H.R. Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. J. Stud. Alcohol 2002, 63:83-90.
69. Rivalan M., Grégoire S., Dellu-Hagedorn F. Reduction of impulsivity with amphetamine in an appetitive fixed consecutive number schedule with cue for optimal performance in rats. Psychopharmacology 2007, 192:171-182.
70. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 1989, 98:408-411.
71. Russo S.J., Sun W.L., Minerly A.C., Weierstall K., Nazarian A., Festa E.D., Niyomchai T., Akhavan A., Luine V., Jenab S., Quiñones-Jenab V. Progesterone attenuates cocaine-induced conditioned place preference in female rats. Brain Res. 2008, 1189:229-235.
72. Simon J.A., Robinson D.E., Andrews M.C., Hildebrand J.R., Rocci M.L., Blake M.E., Hodgen G.D. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril. 1993, 60:26-33.
73. Sinha R., Fox H., Hong K.I., Sofuoglu M., Morgan P.T., Bergquist K.T. Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility. Exp. Clin. Psychopharmacol. 2007, 15:445-452.
74. Söderpalm A.H., Lindsey S., Purdy R.H., Hauger R., de Wit H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 2004, 29:339-354.
75. Sofuoglu M., Babb D.A., Hatsukami D.K. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol. Biochem. Behav. 2001, 69:299-304.
76. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol. Biochem. Behav. 2002, 72:431-435.
77. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 1999, 7:274-283.
78. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol. Biochem. Behav. 2004, 78:699-705.
79. Sofuoglu M., Mitchell E., Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum. Psychopharmacol. 2009, 24:559-564.
80. Sofuoglu M., Poling J., Gonzalez G., Gonsai K., Oliveto A., Kosten T.R. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Exp. Clin. Psychopharmacol. 2007, 15:453-460.
81. Spielberger C.D., Gorsuch R.L., Lushene R.E. STAI Manual for the State-Trait Anxiety Inventory ("Self-Evaluation Questionnaire") 1970, CA, Consulting Psychologists Press, Inc, Palo Alto.
82. Stoops W.W., Lile J.A., Robbins C.G., Martin C.A., Rush C.R., Kelly T.H. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict. Behav. 2007, 32:1177-1188.
83. Office of Applied Studies 2008, Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, (NSDUH), Rockville, MD.
84. Office of Applied Studies 2007, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS, Rockville, MD.
85. van Broekhoven F., Bäckström T., Verkes R.J. Oral progesterone decreases saccadic eye velocity and increases sedation in women. Psychoneuroendocrinology 2006, 31:1190-1199.
86. Volkow N.D., Wang G.-J., Ma Y., Fowler J.S., Wong C., Ding Y.-S., Hitzemann R., Swanson J.M., Kalivas P. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J. Neurosci. 2005, 25:3932-3939.
87. Wade T.R., de Wit H., Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology 2000, 150:90-101.
88. White T.L., Justice A.J., de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 2002, 73:729-741.
89. White T.L., Lejuez C.W., de Wit H. Personality and gender differences in effects of d-amphetamine on risk taking. Exp. Clin. Psychopharmacol. 2007, 15:599-609.
90. Winstanley C.A., Theobald D.E., Dalley J.W., Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 2005, 30:669-682.
91. Zuckerman M., Eysenck S., Eysenck H.J. Sensation seeking in England and America: cross-cultural, age and sex comparisons. J. Consult. Clin. Psychol. 1978, 46:139-149.